Tokyo, June 28, 2018 - Astellas Pharma Inc. (President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced that it has been selected for the seventh consecutive year to be included in the FTSE4Good Index Series, one of the world’s premier indices for socially responsible investment. Out of 14 themes, Astellas received high marks for “Climate Change”, “Labor Standards” and “Corporate Governance”.
Created by the global index provider FTSE Russell1, the FTSE4Good Index Series is designed to measure the performance of companies demonstrating strong Environmental, Social and Governance (ESG) practices. FTSE Russell uses unique criteria which contain 14 themes relevant to environmental, social and governance practices. The FTSE4Good Index Series is used by a wide variety of market participants to create and assess responsible investment funds and other products.
By fulfilling its corporate social responsibility as a pharmaceutical company, Astellas strives to enhance the sustainability of society and consequently improve its enterprise value.
(1) FTSE Russell: a global index leader 100% owned by London Stock Exchange.